Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson, +249

The Lancet Oncology

Breast OncologyMedicineCancer ManagementGynecologyBreast Cancer +5

Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial

Eva Ciruelos, Patricia Villagrasa, Tomás Pascual, +24

Clinical Cancer Research

Recent Changes in Breast Cancer Incidence in Spain, 1980–2004

Marina Pollán, Roberto Pastor‐Barriuso, Eva Ardanáz, +25

JNCI Journal of the National Cancer Institute

A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade

Paolo Nucíforo, Tomás Pascual, Javier Cortés, +17

Annals of Oncology

Predictive ModelTumor CellularityCancer ImmunosurveillanceBreast OncologyMedicine +10

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade

Fara Brasó‐Maristany, Gaia Griguolo, Tomás Pascual, +25

Nature Communications

Variation in ‘standard care’ for breast cancer across Europe: A EUROCARE-3 high resolution study

Claudia Allemani, Hans H. Storm, Adri C. Voogd, +24

European Journal of Cancer

NursingBreast OncologyHealth PolicyMedicineCancer Management +5

Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer

Gaia Griguolo, Garazi Serna, Tomás Pascual, +19

npj Precision Oncology

Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain

I. Esteban, Marta Vilaró, Encarna Adrover, +33

Psycho-Oncology

Influence of stage at diagnosis on survival differences for rectal cancer in three European populations

Élisabeth Monnet, Jean Faivre, L. Raymond, +1

British Journal of Cancer

Attenuation of the epidemic increase in non-Hodgkin's lymphomas in Spain

Rafael Marcos‐Gragera, Marina Pollán, M‐D Chirlaque, +3

Annals of Oncology

Epidemic IncreaseLymphoid NeoplasiaEpidemiologyEpidemic IntelligenceVirus Epidemiology +7